ImmGenics Pharmaceuticals

Vancouver, Canada Founded: 1993 • Age: 33 yrs Acquired By Abgenix
Technology for antibody drug discovery.
Request Access

About ImmGenics Pharmaceuticals

ImmGenics Pharmaceuticals is a company based in Vancouver (Canada) founded in 1993 was acquired by Abgenix in September 2000.. ImmGenics Pharmaceuticals operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

  • Headquarter Vancouver, Canada
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $6 M (USD), Post-IPO

    May 16, 2000

  • Investors
    Nomura

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Abgenix

    (Sep 26, 2000)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ImmGenics Pharmaceuticals

  • Total Funding
  • Total Rounds 1
  • Last Round Post-IPO — $6.0M
  • First Round

    (16 May 2000)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2000 Amount Post-IPO - ImmGenics Pharmaceuticals Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ImmGenics Pharmaceuticals

ImmGenics Pharmaceuticals has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Nomura and Abgenix. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Diversified asset management services are offered globally by the firm.
Founded Year Domain Location
Fully human therapeutic antibodies for cancer and inflammation are discovered.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ImmGenics Pharmaceuticals

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ImmGenics Pharmaceuticals

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Immgenics Pharmaceuticals Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ImmGenics Pharmaceuticals

ImmGenics Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
domain founded_year HQ Location
Yeast cells are genetically engineered to produce medicinal products.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
CRISPR-engineered cell and gene therapies are developed for research applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Immgenics Pharmaceuticals

Frequently Asked Questions about ImmGenics Pharmaceuticals

When was ImmGenics Pharmaceuticals founded?

ImmGenics Pharmaceuticals was founded in 1993 and raised its 1st funding round 7 years after it was founded.

Where is ImmGenics Pharmaceuticals located?

ImmGenics Pharmaceuticals is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.

What does ImmGenics Pharmaceuticals do?

ImmGenics Pharmaceuticals was founded in 1993 in Vancouver, Canada, within the biotechnology sector. A proprietary lymphocyte antibody technology was created, by which B-cells are cultured directly and assayed over several days via a microplate-based throughput system. Greater numbers of antibodies can be screened for specific antigen targets as a result. Operations centered on advancing drug discovery processes until acquisition by Abgenix in November 2000.

Who are the top competitors of ImmGenics Pharmaceuticals?

ImmGenics Pharmaceuticals's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Who are ImmGenics Pharmaceuticals's investors?

ImmGenics Pharmaceuticals has 2 investors. Key investors include Nomura, and Abgenix.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available